Search results
Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)
ETF DAILY NEWS· 5 days agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...
Baby Boomers' 14 Least Favorite Drug Brands: Ranked
247wallst.com· 3 days agoBaby boomers are currently one of the oldest demographics. For this reason, they’re also some of the most familiar with medications. But with so many...
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use...
Benzinga· 5 days agoFood and Drug Administration (FDA) regarding the development of CannQuit-O for treatment of Opioid Use Disorder (OUD). The pre-IND teleconference included representatives ...
Amgen (NASDAQ:AMGN) Price Target Cut to $328.00
ETF DAILY NEWS· 7 days agoAmgen (NASDAQ:AMGN – Get Free Report) had its price target reduced by Royal Bank of Canada from $332.00 to $328.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently ...
Amgen (NASDAQ:AMGN) Shares Down 2.7% on Insider Selling
ETF DAILY NEWS· 5 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) shares were down 2.7% on Monday after an insider sold shares in the company. The company traded as low as $301.09 and last traded at $302.91. Specifically ...
Managing Comorbidities in Chronic Urticaria
MedPage Today· 3 days agoThe link between chronic urticaria and atopic diseases, autoimmune diseases, and psychiatric disorders has significant implications for clinical practice. Managing comorbidities is key to optimizing ...
StockNews.com Upgrades Assertio (NASDAQ:ASRT) to “Buy”
ETF DAILY NEWS· 3 days agoAssertio (NASDAQ:ASRT – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday ...
Fisher Asset Management LLC Acquires 127,228 Shares of Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 5 days agoFisher Asset Management LLC increased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 130.7% in the 4th quarter, according to the company in its most recent filing with the ...
Amgen (NASDAQ:AMGN) Rating Increased to Outperform at William Blair
ETF DAILY NEWS· 7 days agoAmgen (NASDAQ:AMGN – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Friday, MarketBeat ...
We have some good news about cannabis research
Mother Jones· 4 days agoFight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters. After more than 50 years as a Schedule I substance, marijuana is slated to get reclassified ...